Smoot Betty, Paul Steven M, Aouizerat Bradley E, Elboim Charles, Levine Jon D, Abrams Gary, Hamolsky Deborah, Neuhaus John, Schmidt Brian, West Claudia, Topp Kimberly, Miaskowski Christine
1 Department of Physical Therapy and Rehabilitation Science, University of California San Francisco , San Francisco, California.
Lymphat Res Biol. 2014 Sep;12(3):189-93. doi: 10.1089/lrb.2013.0038. Epub 2014 May 16.
Understanding normal volume asymmetry is essential for accurate assessment of limb volume changes following breast cancer (BC) treatment in which lymphatic function is disrupted. The purposes of this study were to evaluate for differences in dominant and nondominant limb volumes and to evaluate for interactions between the effects of dominance and side of cancer on limb volume.
This study evaluated preoperative limb volumes of 397 women enrolled in a prospective, longitudinal study of neuropathic pain and lymphedema. Volume was calculated from circumference. Limb resistance was measured with bioimpedance. Women were dichotomized into two groups: those whose cancer was on their dominant side and those whose cancer was on their nondominant side. Analyses of variance were used to evaluate for differences. In 47%, BC occurred on the side of the dominant limb. Except for the 30 to 40 centimeter (cm) limb volume segment, a main effect of dominance was found for all measures. The volume of the dominant limb was significantly greater than that of the nondominant limb. No main effects were found for side of cancer. A statistically significant interaction was found only at the 0 to 10 cm limb volume segment.
Prior to BC treatment, the dominant limb demonstrated lower bioimpedance resistance (-2.09%) and greater total limb volume (1.12%) than the nondominant limb. Segmental volume differences were greatest at the proximal forearm segment (2.31%) and least at the proximal arm segment (0.21%). This study provides evidence that preoperative volume assessment is important due to normal variability associated with limb dominance.
了解正常的肢体体积不对称对于准确评估乳腺癌(BC)治疗后肢体体积变化至关重要,因为乳腺癌治疗会破坏淋巴功能。本研究的目的是评估优势侧和非优势侧肢体体积的差异,并评估优势侧和患癌侧对肢体体积影响之间的相互作用。
本研究评估了397名参与神经病理性疼痛和淋巴水肿前瞻性纵向研究的女性术前的肢体体积。通过周长计算体积。用生物电阻抗测量肢体电阻。将女性分为两组:癌症位于优势侧的女性和癌症位于非优势侧的女性。使用方差分析来评估差异。47%的乳腺癌发生在优势侧肢体。除了30至40厘米(cm)的肢体体积段外,所有测量指标均发现优势侧有主要影响。优势侧肢体的体积明显大于非优势侧肢体。未发现患癌侧有主要影响。仅在0至10厘米的肢体体积段发现了具有统计学意义的相互作用。
在乳腺癌治疗前,优势侧肢体的生物电阻抗阻力比非优势侧肢体低(-2.09%),总肢体体积比非优势侧肢体大(1.12%)。节段性体积差异在前臂近端段最大(2.31%),在上臂近端段最小(0.21%)。本研究提供了证据,表明由于与肢体优势相关的正常变异性,术前体积评估很重要。